exp:news_feed:department site="neurology" category_id="291" parse="inward" year="" month="" count="5"

News

Tatjana Rundek, M.D., Ph.D.

Dr. Tatjana Rundek and Shelly Baer Receive ‘In the Company of Women’ Awards

Two outstanding women at the University of Miami Miller School of Medicine were honored at the 31st annual “In the Company of Women” awards ceremony, which showcased the contributions of 15 local women leaders. Tatjana Rundek, M.D., Ph.D., was co-winner of the Outstanding Woman in Science and Technology award, and Rochelle A. “Shelly” Baer, M.S.W., L.C.S.W., received the Outstanding Woman in Health and Human Services award.

Read more »

High Number of Depression Symptoms Linked to Increased Risk of Stroke

People who report an elevated number of depression symptoms may be more likely to have a stroke years later than people with no depression symptoms or a low number of depression symptoms, according to a preliminary study released March 6 that will be presented at the American Academy of Neurology’s 71st Annual Meeting in Philadelphia in May.

Read more »

Miller School of Medicine Sets New Record in NIH Research Grant Funding

The University of Miami Miller School of Medicine received a record $133.5 million in research grants from the National Institutes of Health in Federal Fiscal Year 2018 — a $12.8 million increase over the school’s FFY 2017 total, raising the school another point to No. 40 of 147 institutions in the national rankings.

Read more »

A team of UHealth neurosurgeons and neurologists was the first in the eastern U.S., and the second in the nation, to implant the Vercise Cartesia Directional Lead.

UHealth Parkinson’s Experts Continue to Advance Deep Brain Stimulation with Newer Surgical Options

Neurologists and neurosurgeons at UHealth – the University of Miami Health System are continuing to advance Deep Brain Stimulation for people with Parkinson’s Disease. Among the health system’s latest surgical advances, the team recently became the first in the eastern U.S. and the second in the nation to implant the Vercise Cartesia Directional Lead.

Read more »

UM Neurologists Test New Drug to Potentially Slow Progression of Alzheimer’s Disease

Neurologists and researchers with the University of Miami Miller School of Medicine and the University of Miami Health System have begun screening study participants for a new national Alzheimer’s disease (AD) clinical study to evaluate the potential benefits of an investigational medicine for people with mild to moderate Alzheimer’s.

Read more »